ANIX Anixa Biosciences Inc

ITUS Corp is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers.

As of 04/13/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  10/14/2013
Outstanding shares:  31,431,200
Average volume:  835,747
Market cap:   $148,040,952
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    03528H109
ISIN:        US03528H1095
Sedol:      BF7NLD6
Valuation   (See tab for details)
PE ratio:   -67.04
PB ratio:   13.05
PS ratio:   288.86
Return on equity:   -54.56%
Net income %:   -1,447.84%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy